CSIMarket


Abbvie inc   (ABBV)
Other Ticker:  
 

Abbvie inc

ABBV's Fundamental analysis








Looking into Abbvie Inc growth rates, revenue grew by 1.58 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 2101

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.56 %

Abbvie Inc 's net profit deacreased by -38.89 % in IV. Quarter 2022 year on year, to $2,472 millions.

More on ABBV's Growth


Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbvie Inc PEG ratio is at 9.93 Abbvie Inc realized cash outflow of $ -0.31per share in trailing twelve-month period.
Company
24.08
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 4.9.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.65.


More on ABBV's Valuation
 
 Total Debt (Millions $) 63,271
 Dividend TTM ($) 5.65 $
 Dividend Yield TTM (%) 3.53 %
 Revenue/Employee (TTM) $ 1,161,080
 Net Income/Employee (TTM) $ 236,900
 Receivable Turnover (TTM) 5.28
 Tangible Book Value (Per Share $) -46.11

Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbvie Inc PEG ratio is at 9.93 Abbvie Inc realized cash outflow of $ -0.31per share in trailing twelve-month period.
Company
24.08
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 4.9.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.65.

Abbvie Inc Price to Book Ratio is at 16.46 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

More on ABBV's Valuation

  Market Capitalization (Millions $) 284,510
  Shares Outstanding (Millions) 1,785
  Employees 50,000
  Revenues (TTM) (Millions $) 58,054
  Net Income (TTM) (Millions $) 11,845
  Cash Flow (TTM) (Millions $) -545
  Capital Exp. (TTM) (Millions $) -695
  Total Debt (Millions $) 63,271
  Dividend TTM ($) 5.65 $
  Dividend Yield TTM (%) 3.53 %
  Revenue/Employee (TTM) $ 1,161,080
  Net Income/Employee(TTM) $ 236,900
  Receivable Turnover Ratio (TTM) 5.28
  Tangible Book Value (Per Share $) -46.11

  Market Capitalization (Millions $) 284,510
  Shares Outstanding (Millions) 1,785
  Employees 50,000
  Revenues (TTM) (Millions $) 58,054
  Net Income (TTM) (Millions $) 11,845
  Cash Flow (TTM) (Millions $) -545
  Capital Exp. (TTM) (Millions $) -695


    ABBV's Profitability Comparisons
Abbvie Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 36.39 % from 31.08 % in III. Quarter.

Abbvie Inc net profit margin of 16.35 % is currently ranking no. 47 in Major Pharmaceutical Preparations industry, ranking no. 93 in Healthcare sector and number 1022 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 0.96
  Total Debt to Equity (MRQ) 3.66
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.41
  Inventory Turnover Ratio (TTM) 5.11



Abbvie Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 36.39 % from 31.08 % in III. Quarter.

Abbvie Inc net profit margin of 16.35 % is currently ranking no. 47 in Major Pharmaceutical Preparations industry, ranking no. 93 in Healthcare sector and number 1022 in S&P 500.

More on ABBV's Key Ratios



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AYRO's Profile

Stock Price

AYRO's Financials

Business Description

Fundamentals

Charts & Quotes

AYRO's News

Suppliers

AYRO's Competitors

Customers & Markets

Economic Indicators

AYRO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071